Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Nitschmann

Showing results (161-170 of 222) with videos related to

Pageof 23
Sort By:
Der Internist|November 11, 2009
[Optimal time for antiretroviral therapy of HIV infection: NA-ACCORD (North American AIDS cohort collaboration on research and design)]B Jensen, S Nitschmann, D Häussinger
Der Internist|March 4, 2018
[The 20-year results of 5‑year hormone therapy in breast cancer : Early Breast Cancer Trialists' Collaborative Group (EBCTCG)]L Traub, M Thill, S Nitschmann
Innere Medizin (Heidelberg, Germany)|February 14, 2023
[Chlorthalidone in chronic kidney disease]M van der Giet, S Nitschmann
Innere Medizin (Heidelberg, Germany)|May 15, 2024
[Bulevirtide for the treatment of hepatitis B with hepatitis D virus coinfection]Elena Durmashkina, Christoph Sarrazin, S Nitschmann
Der Internist|November 24, 2018
[Development and validation of a hospital frailty risk score for older people]U Hoffmann, C Sieber, S Nitschmann
Der Internist|February 22, 2022
[Erratum to: Shortening and de-escalation of dual antiplatelet therapy]M Halbach, S Baldus, S Nitschmann
Der Internist|April 4, 2022
[Antibody therapy in patients with COVID-19]M Augustin, M Hallek, S Nitschmann
Der Internist|March 9, 2022
[Risk of myocarditis associated with mRNA vaccines for prevention of COVID-19]M Augustin, M Hallek, S Nitschmann
Der Internist|April 4, 2019
[Treatment of multiple myeloma with elotuzumab plus pomalidomide and dexamethasone]L Rasche, H Einsele, S Nitschmann
Der Internist|July 2, 2005
[Detail study of angiotensin-receptor blockade versus ACE-inhibition in type 2 diabetes with nephropathy]S Nitschmann, M Girndt, H Köhler
Pageof 23

Showing results (161-170 of 222) with videos related to

Sort By:
Pageof 23
Der Internist|November 11, 2009
[Optimal time for antiretroviral therapy of HIV infection: NA-ACCORD (North American AIDS cohort collaboration on research and design)]B Jensen, S Nitschmann, D Häussinger
Der Internist|March 4, 2018
[The 20-year results of 5‑year hormone therapy in breast cancer : Early Breast Cancer Trialists' Collaborative Group (EBCTCG)]L Traub, M Thill, S Nitschmann
Innere Medizin (Heidelberg, Germany)|February 14, 2023
[Chlorthalidone in chronic kidney disease]M van der Giet, S Nitschmann
Innere Medizin (Heidelberg, Germany)|May 15, 2024
[Bulevirtide for the treatment of hepatitis B with hepatitis D virus coinfection]Elena Durmashkina, Christoph Sarrazin, S Nitschmann
Der Internist|November 24, 2018
[Development and validation of a hospital frailty risk score for older people]U Hoffmann, C Sieber, S Nitschmann
Der Internist|February 22, 2022
[Erratum to: Shortening and de-escalation of dual antiplatelet therapy]M Halbach, S Baldus, S Nitschmann
Der Internist|April 4, 2022
[Antibody therapy in patients with COVID-19]M Augustin, M Hallek, S Nitschmann
Der Internist|March 9, 2022
[Risk of myocarditis associated with mRNA vaccines for prevention of COVID-19]M Augustin, M Hallek, S Nitschmann
Der Internist|April 4, 2019
[Treatment of multiple myeloma with elotuzumab plus pomalidomide and dexamethasone]L Rasche, H Einsele, S Nitschmann
Der Internist|July 2, 2005
[Detail study of angiotensin-receptor blockade versus ACE-inhibition in type 2 diabetes with nephropathy]S Nitschmann, M Girndt, H Köhler
Pageof 23